A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 85,600 shares of SRTS stock, worth $620,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,600
Previous 166,100 48.46%
Holding current value
$620,600
Previous $885,000 43.95%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.93 - $7.05 $396,865 - $567,525
-80,500 Reduced 48.46%
85,600 $496,000
Q2 2024

Aug 14, 2024

BUY
$3.14 - $6.42 $268,156 - $548,268
85,400 Added 105.82%
166,100 $885,000
Q1 2024

May 15, 2024

SELL
$2.49 - $4.91 $19,422 - $38,298
-7,800 Reduced 8.81%
80,700 $306,000
Q4 2023

Feb 14, 2024

SELL
$1.87 - $2.71 $29,920 - $43,360
-16,000 Reduced 15.31%
88,500 $208,000
Q3 2023

Nov 14, 2023

BUY
$2.62 - $3.91 $88,556 - $132,158
33,800 Added 47.81%
104,500 $289,000
Q2 2023

Aug 14, 2023

BUY
$2.62 - $5.28 $91,962 - $185,328
35,100 Added 98.6%
70,700 $222,000
Q1 2023

May 15, 2023

BUY
$4.9 - $9.49 $16,170 - $31,317
3,300 Added 10.22%
35,600 $185,000
Q4 2022

Feb 14, 2023

BUY
$5.91 - $14.28 $12,411 - $29,988
2,100 Added 6.95%
32,300 $239,000
Q3 2022

Nov 14, 2022

BUY
$7.64 - $14.97 $38,964 - $76,347
5,100 Added 20.32%
30,200 $378,000
Q2 2022

Aug 15, 2022

SELL
$7.06 - $11.37 $183,560 - $295,620
-26,000 Reduced 50.88%
25,100 $193,000
Q1 2022

May 16, 2022

BUY
$6.83 - $11.84 $118,159 - $204,832
17,300 Added 51.18%
51,100 $517,000
Q4 2021

Feb 14, 2022

BUY
$3.59 - $8.34 $121,342 - $281,892
33,800 New
33,800 $244,000

Others Institutions Holding SRTS

About Sensus Healthcare, Inc.


  • Ticker SRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,556,000
  • Market Cap $120M
  • Description
  • Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...
More about SRTS
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.